Comparison of two immunoassays for determining hepatitis B virus serum markers

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 1, 2012, Pages 153-157

  Xu, Wanzhou ^a   Li, Yan ^a   Wang, Ming ^a   Gu, Jian ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Anti HBe; Anti HBs; Electrochemiluminescence immunoassay; Enzyme linked immunosorbent assay; HBeAg; HBsAg; Serum HBV markers

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ACCURACY; ANALYTIC METHOD; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CHEMOLUMINESCENCE; DIAGNOSTIC ACCURACY; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

HEPATITIS B VIRUS;

EID: 84863234858     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.721     Document Type: Article

References (19)

1. Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009;49:S13-21.
2. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2:395-403.
3. Akuta N, Kumada H. Influence of hepatitis B virus genotypes on the response to antiviral therapies. J Antimicrob Chemoth 2005;55:139-42. (Pubitemid 40331136)
4. Cambron P, Jacquet JM, Hoet B, Lievens M. Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccine. Clin Vaccine Immunol 2009;16: 1236-46.
5. Diepersloot RJ, van Zantvliet-van Oostrom Y, Gleaves CA. Comparison of a chemiluminescent immunoassay with two microparticle enzyme immunoassays for detection of hepatitis B virus surface antigen. Clin Diagn Lab Immun 2000;7:865-6. (Pubitemid 32244479)
6. Chen D, Kaplan L, Liu Q. Evaluation of two chemiluminescent immunoassays of ADVIA Centaur for hepatitis B serology markers. Clin Chim Acta 2005;355:41-5.
7. Chen Y, Wu W, Li LJ, Lou B, Zhang J, Fan J. Comparison of the results for three automated immunoassay systems in determining serum HBV markers. Clin Chim Acta 2006;372:129-33. (Pubitemid 44308319)
8. Weber B, Van der Taelem-Brulé N, Berger A, Simon F, Geudin M, Ritter J. Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra. J Virol Methods 2006;135:109-17. (Pubitemid 43744433)
9. Colomina-Rodríguez J, González-García D, Burgos-Teruel A, Fernández-Lorenz N, Guerrero-Espejo A. Significance of hepatitis B core antibody as the only marker of hepatitis B infection. Enferm Infecc Microbiol Clin 2005;23:80-5. (Pubitemid 40486605)
10. Fong TL, Di Bisceglie AM, Biswas R, Waggoner JG, Wilson L, Claggett J, et al. High levels of viral replication during acute hepatitis B infection predict progression to chronicity. J Med Virol 1994;43:155-8. (Pubitemid 24236656)
11. Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 2010;51:1933-44.
12. Huang X, Qin Y, Zhang P, Tang G, Shi Q, Xu J, et al. PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies. J Med Virol 2010;82:23-31.
13. Gerlich WH. The enigma of concurrent hepatitis B surface antigen (HBsAg) and antibodies to HBsAg. Clin Infect Dis 2007;44:1170-2. (Pubitemid 46651240)
14. Yang Q, Gong ZJ, Hu DF. A clinical study of adefovir dipi-voxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period. Zhonghua Gan Zang Bing Za Zhi 2007;15:821-4.
15. Chen M, Sällberg M, Hughes J, Jones J, Guidotti LG, Chisari F V, et al. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 2005;79:3016-27. (Pubitemid 40270581)
16. Lee YI, Hur GM, Suh DJ, Kim SH. Novel pre-C/C gene mutants of hepatitis B virus in chronic active hepatitis: naturally occurring escape mutants. J Gen Virol 1996;77:1129-38. (Pubitemid 26185490)
17. Chen MT, Billaud J-N, Sällberg M, Guidotti LG, Chisari F V, Jones J, et al. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci USA 2004;101:14913-8. (Pubitemid 39410774)
18. Yang CY, Kuo TH, Ting LP. Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response. J Biol Chem 2006;281:34525-36.
19. Erhardt A, Reineke U, Blondin D, Gerlich WH, Adams O, Heintges T, et al. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 2000;31:716-25. (Pubitemid 30118641)